Clinical Trial Update: Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating D-cycloserine plus cognitive behavioral therapy for social anxiety disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder
• Social Phobia

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Boston University Charles River Campus | Conditions: Social Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-07-23